NASDAQ:MIST

Milestone Pharmaceuticals News Headlines

$5.63
-0.07 (-1.23 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.27
Now: $5.63
$5.82
50-Day Range
$5.59
MA: $6.87
$8.05
52-Week Range
$2.05
Now: $5.63
$11.40
Volume142,357 shs
Average Volume105,852 shs
Market Capitalization$168.03 million
P/E RatioN/A
Dividend YieldN/A
Beta4.2

Headlines

Milestone Pharmaceuticals (NASDAQ MIST) News Headlines Today

SourceHeadline
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) to Post FY2021 Earnings of ($1.92) Per Share, Jefferies Financial Group ForecastsMilestone Pharmaceuticals Inc. (NASDAQ:MIST) to Post FY2021 Earnings of ($1.92) Per Share, Jefferies Financial Group Forecasts
americanbankingnews.com - April 2 at 8:36 AM
Q1 2021 EPS Estimates for Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Boosted by OppenheimerQ1 2021 EPS Estimates for Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Boosted by Oppenheimer
americanbankingnews.com - April 2 at 7:48 AM
Research Analysts Issue Forecasts for Milestone Pharmaceuticals Inc.s Q1 2021 Earnings (NASDAQ:MIST)Research Analysts Issue Forecasts for Milestone Pharmaceuticals Inc.'s Q1 2021 Earnings (NASDAQ:MIST)
americanbankingnews.com - April 1 at 7:16 AM
Milestone Pharmaceuticals (NASDAQ:MIST) Issues  Earnings ResultsMilestone Pharmaceuticals (NASDAQ:MIST) Issues Earnings Results
americanbankingnews.com - March 30 at 7:46 AM
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Recommendation of "Buy" by AnalystsMilestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Recommendation of "Buy" by Analysts
americanbankingnews.com - March 30 at 6:38 AM
Should Investors Consider Buying These Top Health In March? 4 To WatchShould Investors Consider Buying These Top Health In March? 4 To Watch
nasdaq.com - March 5 at 5:35 PM
How Much Of Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Do Institutions Own?How Much Of Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Do Institutions Own?
finance.yahoo.com - February 1 at 3:11 PM
MIST Jan 2021 7.500 callMIST Jan 2021 7.500 call
uk.finance.yahoo.com - December 28 at 10:48 PM
MIST Jan 2021 7.500 putMIST Jan 2021 7.500 put
uk.finance.yahoo.com - December 28 at 10:48 PM
MIST Jan 2021 10.000 callMIST Jan 2021 10.000 call
uk.finance.yahoo.com - December 24 at 1:18 AM
Lobe Sciences Ltd.: Lobe Sciences Commences Engineering of Nasal Mist DeviceLobe Sciences Ltd.: Lobe Sciences Commences Engineering of Nasal Mist Device
finanznachrichten.de - December 3 at 8:25 AM
Is Milestone Pharmaceuticals (MIST) A Good Stock To Buy Now?Is Milestone Pharmaceuticals (MIST) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 10:24 PM
TAICCA and Golden Horse FPP Series Introduce Promising Proposals to International InvestorsTAICCA and Golden Horse FPP Series Introduce Promising Proposals to International Investors
finance.yahoo.com - December 2 at 7:46 AM
Government of Canada Creates Task Force on Flood Insurance and RelocationGovernment of Canada Creates Task Force on Flood Insurance and Relocation
finance.yahoo.com - November 23 at 10:04 PM
First patient enrolled in Milestone Pharmaceuticals late-stage study of etripamil in PSVTFirst patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT
seekingalpha.com - November 18 at 8:38 AM
Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVTMilestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
finance.yahoo.com - November 18 at 8:38 AM
Milestone Pharmaceuticals EPS beats by $0.09Milestone Pharmaceuticals EPS beats by $0.09
seekingalpha.com - November 13 at 12:35 PM
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate UpdateMilestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
finance.yahoo.com - November 13 at 7:24 AM
Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare ConferenceMilestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 11 at 8:38 AM
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q3 2020 Results - Earnings Call TranscriptEyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 3:37 AM
Milestone Pharma down 18% after pricing $45M equity offeringMilestone Pharma down 18% after pricing $45M equity offering
seekingalpha.com - October 24 at 8:59 AM
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded WarrantsMilestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
finance.yahoo.com - October 23 at 8:53 AM
Milestone Pharmaceuticals launches equity offeringMilestone Pharmaceuticals launches equity offering
seekingalpha.com - October 22 at 5:58 PM
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded WarrantsMilestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
finance.yahoo.com - October 22 at 5:58 PM
Financials Milestone PharmaceuticalsFinancials Milestone Pharmaceuticals
markets.businessinsider.com - September 30 at 7:30 PM
Milestone Pharmaceuticals Is Good for Your Heart, Unless You’re an InvestorMilestone Pharmaceuticals Is Good for Your Heart, Unless You’re an Investor
msn.com - August 26 at 1:20 PM
Milestone Pharma launches 6.7M-share secondary offeringMilestone Pharma launches 6.7M-share secondary offering
seekingalpha.com - August 21 at 9:44 AM
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate UpdateMilestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
finance.yahoo.com - August 12 at 8:23 AM
Why Earnings Season Could Be Great for Milestone Pharmaceuticals (MIST)Why Earnings Season Could Be Great for Milestone Pharmaceuticals (MIST)
finance.yahoo.com - August 10 at 11:12 AM
Bullish US Stocks Which Surged In Month: $MIST $TUP $SOGOBullish US Stocks Which Surged In Month: $MIST $TUP $SOGO
marketwatch.com - August 7 at 3:08 AM
How Many Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Do Institutions Own?How Many Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Do Institutions Own?
finance.yahoo.com - August 4 at 1:42 PM
Juggling Risk And Reward In A Raucous MarketJuggling Risk And Reward In A Raucous Market
finance.yahoo.com - July 24 at 8:27 PM
Milestone Pharmaceuticals (MIST) Hits a Couple Milestones After FDA Meeting; Top Analyst CheersMilestone Pharmaceuticals (MIST) Hits a Couple Milestones After FDA Meeting; Top Analyst Cheers
finance.yahoo.com - July 24 at 8:27 PM
Mid-Afternoon Market Update: Dow Tumbles 400 Points; Milestone Pharmaceuticals Shares GainMid-Afternoon Market Update: Dow Tumbles 400 Points; Milestone Pharmaceuticals Shares Gain
www.benzinga.com - July 23 at 6:18 PM
Thinking about buying stock in Milestone Pharmaceuticals, Advanced Micro Devices, CymaBay Therapeutics, Pfizer Inc, or AT&T?Thinking about buying stock in Milestone Pharmaceuticals, Advanced Micro Devices, CymaBay Therapeutics, Pfizer Inc, or AT&T?
www.marketwatch.com - July 23 at 1:18 PM
Milestone Pharmas Next Big Move After FDA NodMilestone Pharma's Next Big Move After FDA Nod
www.msn.com - July 23 at 1:18 PM
Milestone Pharma provides update on late stage etripamil study; secures $25M in equityMilestone Pharma provides update on late stage etripamil study; secures $25M in equity
seekingalpha.com - July 23 at 1:18 PM
Stock Alert: Milestone Pharma Spikes On Etripamil Update; $25 Mln Private PlacementStock Alert: Milestone Pharma Spikes On Etripamil Update; $25 Mln Private Placement
www.nasdaq.com - July 23 at 1:18 PM
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVTMilestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
finance.yahoo.com - July 23 at 7:59 AM
Milestone Pharmaceuticals Announces $25 Million Private PlacementMilestone Pharmaceuticals Announces $25 Million Private Placement
finance.yahoo.com - July 23 at 7:59 AM
Milestone Pharmaceuticals Shares March Higher, Can It Continue?Milestone Pharmaceuticals' Shares March Higher, Can It Continue?
finance.yahoo.com - June 12 at 9:19 AM
Milestone Pharmaceuticals cuts salaries to reduce expensesMilestone Pharmaceuticals cuts salaries to reduce expenses
seekingalpha.com - June 9 at 9:39 AM
Milestone Pharmaceuticals Inc. (MIST): Are Hedge Funds Right About This Stock?Milestone Pharmaceuticals Inc. (MIST): Are Hedge Funds Right About This Stock?
finance.yahoo.com - June 5 at 3:16 PM
Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare ConferenceMilestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
finance.yahoo.com - May 27 at 8:33 AM
Will Milestone Pharmaceuticals Continue to Surge Higher?Will Milestone Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - May 20 at 10:23 AM
Backed by US and foreign investors, Canadian VC sets record at $7.263B for 2019Backed by US and foreign investors, Canadian VC sets record at $7.263B for 2019
finance.yahoo.com - May 20 at 10:23 AM
Top Ranked Momentum Stocks to Buy for May 19thTop Ranked Momentum Stocks to Buy for May 19th
finance.yahoo.com - May 19 at 9:39 AM
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate UpdateMilestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
finance.yahoo.com - May 14 at 10:01 AM
Milestone Pharmaceuticals Enters Oversold TerritoryMilestone Pharmaceuticals Enters Oversold Territory
finance.yahoo.com - April 20 at 3:55 PM
Milestone Pharmaceuticals Inc. (MIST)Milestone Pharmaceuticals Inc. (MIST)
ca.finance.yahoo.com - April 19 at 7:00 PM
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.